Literature DB >> 8722216

Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.

J S Wang1, G S Qian, A Zarba, X He, Y R Zhu, B C Zhang, L Jacobson, S J Gange, A Muñoz, T W Kensler.   

Abstract

Molecular epidemiological studies of populations at high risk for liver cancer have shown that hepatitis B virus (HBV) and aflatoxin B1 (AFB1) exposure are two major risk factors for this disease. These etiological agents, combined with nutritional deficiencies, are important for the initiation and promotion of liver cancer in various parts of the world. In Qidong, People's Republic of China, liver cancer accounts for 10% of all adult deaths, and both HBV and AFB1 exposures are common. To study temporal and possible chemical-viral interactions in people, serum samples were collected during a longitudinal study designed to measure aflatoxin molecular biomarkers in residents of Daxin Township, Qidong City, People's Republic of China. In this study, the temporal modulation of aflatoxin adduct formation with albumin over multiple lifetimes of serum albumin was examined in both HBV-positive and HBV-negative people in two periods: September-December 1993 (wave 1) and June-September 1994 (wave 2). During the 12-week monitoring period of wave 1, 120 individuals (balanced by gender and HBV status) provided a total of 792 blood samples. AFB1-albumin adducts were detected in all but one of the serum samples. The range of binding detected by RIA in the Daxin population was 0.17-4.39 pmol AFB11/mg albumin with an overall mean +/- SD of 1.51 +/- 0.21 pmol AFB11/mg albumin. The mean +/- SD for weeks 0, 2, 4, 6, 8, 10 and 12 of wave 1 were 1.21 +/- 0.41, 1.58 +/- 0.70, 1.36 +/- 0.52, 1.71 +/- 0.44, 1.18 +/- 0.60, 2.00 +/- 0.59, and 1.68 +/- 0.34 pmol AFB1/mg albumin, respectively. During wave 2, 103 individuals from wave 1 provided a total of 396 blood samples collected monthly over wave 2, with mean +/- SD aflatoxin-albumin adduct levels of 1.19 +/- 0.37, 0.85 +/- 0.45, 0.89 +/- 0.28, and 0.61 +/- 0.15 pmol AFB1/mg albumin. Using linear regression models, the mean aflatoxin-albumin adduct levels increased (P < 0.05) during the 12 weeks of wave 1 and decreased (P < 0.05) over the 4 months of wave 2. Neither HBV surface antigen status nor gender modified either the baseline mean or the temporal trend. High-performance liquid chromatography confirmation was done on a subset of serum samples, and the results show an excellent association between the immunoassay data and high-performance liquid chromatography. Taken together, these data demonstrate that AFB1-albumin is a sensitive and specific biomarker for assessing exposure to this carcinogen in the population in Qidong.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8722216

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  31 in total

1.  Chemopreventive effect of oltipraz on AFB(1)-induced hepatocarcinogenesis in tree shrew model.

Authors:  Yuan Li; Jian-Jia Su; Liu-Liang Qin; Chun Yang; Dan Luo; Ke-Chen Ban; TW Kensler; BD Roebuck
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Aflatoxin and PAH exposure biomarkers in a U.S. population with a high incidence of hepatocellular carcinoma.

Authors:  Natalie M Johnson; Guoqing Qian; Li Xu; Danielle Tietze; Alicia Marroquin-Cardona; Abraham Robinson; Melanie Rodriguez; Linda Kaufman; Kyle Cunningham; James Wittmer; Fernando Guerra; Kirby C Donnelly; Jonathan H Williams; Jia-Sheng Wang; Timothy D Phillips
Journal:  Sci Total Environ       Date:  2010-09-25       Impact factor: 7.963

3.  Associated factors in modulating aflatoxin B1-albumin adduct level in three Chinese populations.

Authors:  Peng Tao; Liu Zhi-Ming; Liu Tang-Wei; Li Le-Qun; Peng Min-Hao; Qin Xue; Yan Lu-Nam; Liang Ren-Xiang; Wei Zong-Liang; Wang Lian-Wen; Wang Qiao; Shen Han-Ming; Ong Choon-Nam; Regina M Santella
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

4.  Intervention trial with calcium montmorillonite clay in a south Texas population exposed to aflatoxin.

Authors:  Brad H Pollock; Sarah Elmore; Amelia Romoser; Lili Tang; Min-Su Kang; Kathy Xue; Marisa Rodriguez; Nicole A Dierschke; Holly G Hayes; H Andrew Hansen; Fernando Guerra; Jia-Sheng Wang; Timothy Phillips
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2016-07-28

5.  Retrospective and Prospective Look at Aflatoxin Research and Development from a Practical Standpoint.

Authors:  Noreddine Benkerroum
Journal:  Int J Environ Res Public Health       Date:  2019-09-27       Impact factor: 3.390

6.  Association of high viral load and abnormal liver function with high aflatoxin B1-albumin adduct levels in HIV-positive Ghanaians: preliminary observations.

Authors:  P E Jolly; F M Shuaib; Y Jiang; P Preko; J Baidoo; J K Stiles; J-S Wang; T D Phillips; J H Williams
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2011-07-12

7.  Physiologically based toxicokinetics of serum aflatoxin B1-lysine adduct in F344 rats.

Authors:  Guoqing Qian; Lili Tang; Franklin Wang; Xia Guo; Michael E Massey; Jonathan H Williams; Timothy D Phillips; Jia-Sheng Wang
Journal:  Toxicology       Date:  2012-11-09       Impact factor: 4.221

8.  Development of aflatoxin B(1)-lysine adduct monoclonal antibody for human exposure studies.

Authors:  J S Wang; S Abubaker; X He; G Sun; P T Strickland; J D Groopman
Journal:  Appl Environ Microbiol       Date:  2001-06       Impact factor: 4.792

9.  Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma.

Authors:  Zhi-Ming Liu; Le-Qun Li; Min-Hao Peng; Tang-Wei Liu; Zhong Qin; Ya Guo; Kai-Yin Xiao; Xin-Ping Ye; Xin-Shao Mo; Xue Qin; Shan Li; Lu-Nan Yan; Han-Ming Shen; LianWen Wang; Qiao Wang; Kai-bo Wang; Ren-xiang Liang; Zong-liang Wei; Choon Nam Ong; Regina M Santella; Tao Peng
Journal:  Cancer Lett       Date:  2008-02-15       Impact factor: 8.679

Review 10.  Exposure measurement of aflatoxins and aflatoxin metabolites in human body fluids. A short review.

Authors:  Yin-Hui Leong; Aishah A Latiff; Nurul Izzah Ahmad; Ahmad Rosma
Journal:  Mycotoxin Res       Date:  2012-04-03       Impact factor: 3.833

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.